Three trials with 156 crossbred heifers were used to determine the effects of dietary energy and bovine somatotropin administration on subsequent heifer productivity. In Trial 1, heifer calves were weaned from their dams ( n = 28; 113 ± 13 d of age) and assigned to a 2 × 2 factorial arrangement of moderate (MDE) or high dietary energy (HDE) and injections of vehicle (VEH) or 250 mg of bovine somatotropin (bST) every 14 d. Heifer calves in Trial 2 ( n = 28; 123 ± 20 d of age) and Trial 3 ( n = 100; 134 ± 22 d of age) nursed their dams while grazing pasture and received no creep feed (MDE) or ad libitum access to creep feed (HDE) and received VEH or bST as in Trial 1. Treatments were administered for 112 d and heifers within trial were managed alike after that time. There were no dietary treatment × bST treatment interactions for any of the variables analyzed ( P > .05). Dietary energy did not affect daily gain in Trial 1; however, heifers receiving
Introduction
The success of a replacement heifer development program is measured by subsequent heifer fertility and milk production. Reproductive benefits are realized with rapid weight gains of prepubertal heifers (Patterson et al., 1992) ; however, high-energy diets may reduce subsequent milk production in dairy heifers (Waldo and Capuco, 1992) . Likewise, if replacement beef heifers are given access to creep feed, milk production is reduced (Hixon et al., 1982; Buskirk et al., 1996) , thereby lowering lifetime calf weaning weights (Martin et al., 1981) . The deleterious effects of high-energy diets on mammogenesis and milk production have been proposed to be mediated by bovine somatotropin ( bST) . Serum bST is reduced in prepubertal heifers fed high energy (Sejrsen et al., 1983; Houseknecht et al., 1988) and is correlated positively to mammary parenchyma development (Sejrsen et al., 1983) . Based on these observations, it has been hypothesized that endogenous bST may be a limiting factor for mammogenesis in rapidly gaining heifers. This theory would be supported if exogenous bST could overcome the detrimental effects of highenergy diets. Therefore, our objectives were to determine the effects of dietary energy and bST on heifer growth, fertility, milk production and mammary composition.
Experimental Procedures
Trial 1. Twenty-eight Angus-Simmental crossbred heifer calves were weaned from their dams at an age of 113 ± 13 d and brought to the University of Illinois, Urbana Beef Unit, Urbana, IL (Trial 1). After a 3-wk adaptation period, heifers were randomly assigned to a 2 × 2 factorial arrangement of treatments. Heifers had ad libitum access to either moderate dietary energy ( MDE) or high dietary energy ( HDE) designed to provide for average treatment gains of .7 and 1.2 kg/d, respectively (Table 1) . Within each feeding group, heifers received s.c. injections of either vehicle ( VEH) or VEH containing 250 mg of recombinantly derived n-methionyl bovine somatotropin (bST; Monsanto, St. Louis, MO) every 14 d. Injections were made anterior to the scapula, and injection sites alternated between right and left sides of the heifer. Heifers received eight injections during the 112-d treatment period. Fourteen calves were housed in each of two pens (15 × 7.5 m ) in an open-front barn with concrete flooring during the treatment period. Each pen was equipped with a Pinpointer 4000B feeding device (Agricultural Identification Systems, Cookeville, TN) for determination of individual daily feed intake. Representative feed samples were taken monthly, composited, and analyzed for DM and N content by macro-Kjeldahl procedure, method 984.13 (AOAC, 1990) . Shrunk body weights were taken after a 16-h withdrawal from water at 28-d intervals from d 0 to 112. Hip height was measured to a point directly over the hook bones on d 0 and 112, and fat thickness between the 12th and 13th ribs was measured using a real-time linear array ultrasound instrument (model 210 DX, Johnson and Johnson Ultrasound, Englewood, CO) on d 112. Blood samples were taken every 14 d from d 0 to 98 immediately before injections and from d 112 to 168 after the treatment period for analysis of insulin-like growth factor I ( IGF-I) . Blood was collected via jugular venipuncture from all heifers; samples were immediately placed in crushed ice and serum was separated by centrifugation at 1,000 × g for 30 min within 3 h of collection. Serum was stored at −20°C until it was assayed for concentrations of IGF-I. The assay of IGF-I was conducted as reported by Vicini et al. (1991) . Intra-and interassay CV were 13.9 and 10.8%, respectively. Blood samples were taken daily from d 99 to 112 for analysis of bST. Serum was harvested and stored the same as for IGF-I samples. The assay of bST was conducted as reported by Vicini et al. (1991) . Intra-and interassay CV were 11.7 and 15.7%, respectively.
Beginning at d 112, concentrations of progesterone were determined in weekly serum samples until the beginning of the breeding season. Blood was collected via jugular venipuncture and immediately placed in crushed ice to prevent progesterone metabolism (Wiseman et al., 1982) and serum was separated by centrifugation at 1,000 × g for 30 min within 4 h of collection. Serum was stored at −20°C until it was assayed for concentrations of progesterone as determined by a validated enzyme immunoassay (Kesler et al., 1990) . Heifers were considered pubertal after their first serum sample that contained progesterone concentrations ≥ 1.5 ng/mL. Shrunk weights were taken at 28-d intervals from d 112 to the beginning of the breeding season and were interpolated to estimate weight at puberty. Trials 1, 2, and 3. From the conclusion of the 112-d treatment period, heifers within a trial were managed alike through weaning of their first calf. Heifers in Trials 1 and 2 were managed together following the treatment period. During the winter, heifers were given ad libitum access to alfalfa hay and 2 kg/d cracked corn (Trials 1 and 2 ) or grazed tall fescue pasture with ad libitum access to tall fescue hay and a supplement containing 85% cracked corn, 15% white salt, and 41 mg/kg monensin (Trial 3).
When heifers were an average of 13.5 mo of age, estrus was synchronized for all heifers with SyncroMate-B ® (Rhone Merieux, Athens, GA) as described by Favero et al. (1993) , and heifers were artificially inseminated approximately 48 h after removal of the implants. Artificial insemination was performed by one of two inseminators experienced in timed AI. Inseminator and service sire were randomly assigned at the AI. Seven days following AI, all heifers were exposed to fertile bulls in their respective breeding groups for the remainder of the 60-d breeding season. Pregnancy was determined by rectal palpation 150 d after AI and all nonpregnant heifers were removed from the study. Winter feeding consisted of ad libitum access to alfalfa hay and 2.6 kg/d cracked corn (Trial 1 and 2 ) or ad libitum access to tall fescue pasture and hay and 1.8 kg/d cracked corn (Trial 3).
At parturition, heifers were scored according to degree of calving difficulty ( 1 = no difficulty, 2 = minor difficulty, 3 = major difficulty, 4 = Caesarean section, 5 = abnormal presentation). Only calving ease scores of 1 to 4 were included in statistical analysis (BIF, 1990) . Calves were identified and weighed within 24 h after birth and male calves were castrated. Calving dates were used to estimate calving rates to the timed AI (283 ± 11 d from AI). Heifers that did not raise a calf were removed from the study. Over a 6-wk period following calving, dams on Trials 1 and 2 were gradually adjusted to a 91% concentrate, 12.4% CP diet composed of 86% cracked corn, 9% alfalfa hay, and 5% supplement (41% CP) in drylot for the entire preweaning period. Calves had access to the dams' feed during this period. Dams in Trial 3 grazed endophyte-infected tall fescue-red clover ( Trifolium pratense L.) pastures and their calves had no access to supplemental feed during the preweaning period.
Milk production estimates were obtained at 49, 77, 105, 133, and 161 ± 18 d postpartum for dams by calf weigh-suckle-weigh procedures. At approximately 1400, dam-calf pairs were sorted into groups of 10 or fewer and calves were separated from their dams. Beginning at 1900, groups of calves were paired with their dams, allowed to nurse for 15 min, and separated until the following morning. This preliminary separation period and subsequent nursing was designed to leave only residual milk in the mammary gland at the beginning of the measurement period. Calves were denied access to feed and water after the initial separation for the duration of the measurement period. Dams were allowed access to feed and water between nursings. Beginning at 0700, groups of calves were weighed to the nearest .09 kg with electronic scales (Mettler-Toledo model 2158, System Scale, Indianapolis, IN) and paired with their dam. Pairing was done in large open lots so that calves paired quickly and cross-nursing was prevented. Immediately after nursing, each calf was reweighed and returned to its dam. The difference in calf pre-and post-nursing weight was multiplied by 2 to provide an estimate of 24-h milk production. The five milk production estimates were averaged to yield an estimate of average daily milk production.
Milk composition was determined at 146 ± 18 d postpartum by milking machine. At approximately 1400, dam-calf pairs were sorted into groups of two and separated. Beginning at 1900, groups of calves were paired with their dams, allowed to nurse for 15 min, and separated until the following morning. Dams were allowed access to feed and water. Beginning at 0700 dams were restrained in a chute and injected i.m. with 100 U.S.P. units of oxytocin to induce milk letdown, immediately before machine milking. During milking, each gland was massaged until milk flow ceased to ensure that complete milkout had been obtained. The milk was thoroughly mixed and a 120-mL sample was obtained. A preservative (2-bromo-2-nitropropane-1,3 diol, Microtabs ™ , D & F Control Systems, San Ramon, CA) was immediately added to the samples and they were refrigerated at 4°C before analyses. Solids-not-fat ( SNF) concentration was determined according to the procedure of Golding (1959) . Milk fat and protein concentrations were determined by infrared analysis (Dairy Lab Services, Dubuque, IA).
Horizontal and vertical internal pelvic measurements were obtained at breeding and calving by the procedure of Rice and Wiltbank (1972) with a Rice Pelvimeter (Lane Manufacturing, Denver, CO). The two measurements were multiplied to yield an estimate of pelvic area. Body condition score ( BCS) on a 1 to 9 scale (Wagner et al., 1988) was assigned by experienced evaluators and shrunk weights were taken at breeding, calving, and calf weaning. Calves were weaned at an average age of 162 d, and hip height was measured. For females in Trial 3 that remained in production the following year, calves were weaned at an average age of 159 d, and weights were recorded.
Mammary Gland Analysis. All dams in Trials 1 and 2 were slaughtered within 18 h of calf weaning at Iowa Beef Processors, Joslin, IL. Immediately after exsanguination, mammary glands were trimmed of skin and teats and removed as close to the abdominal wall as possible. Milk was allowed to drain, and the glands were individually bagged and placed in dry ice for transport to the University of Illinois, Meat Science Laboratory. Mammary glands were chilled overnight at 4°C. The following morning, the glands were weighed, diced, and ground in a commercial bowl chopper for 3 min. A representative sample was further homogenized in a commercial food processor (model R6Y, Robot Coupe, U.S.A., Ridgeland, MS) for 2 min, and samples were frozen at −20°C until chemical analysis.
All chemical analyses were performed in triplicate. Dry matter was determined by drying at 80°C to constant weight, and ash was determined by method 942.05 (AOAC, 1990) . Samples of tissue from individual glands were subjected to a Soxhlet ether extraction, method 920.39 (AOAC, 1990) to determine the content of dry fat-free tissue ( DFFT) . Fat content was determined by calculation. Crude protein content of individual glands was estimated as 6.25 times Kjeldahl nitrogen, determined using the macro-Kjeldahl procedure, method 984.13 (AOAC, 1990) . For measurement of DNA content, duplicate samples of approximately 5 g of ground mammary tissue were thawed and homogenized in 5 mL of ice-cold buffer (50 mM Tris, .5 mM EDTA, .1 M NaCl, pH 7.4) with three 15-s bursts, at 70% full speed, of a Polytron tissue homogenizer (Brinkman Instruments, Westbury, NY). Approximately 1 g of this homogenate was added to 10 mL of ice-cold buffer and further homogenized with two 15-s bursts of the Polytron. Mammary tissue homogenates were fully disrupted before the assay by freezing at −20°C, thawing, and sonicating for 15 s with a Sonic Disruptor (Tekmar, Cincinnati, OH). Homogenates were diluted in a highsalt buffer (10 mM Tris, 1 mM EDTA, 2 M NaCl, pH 7.4) and concentration of DNA was quantified in triplicate samples by the method of Labarca and Paigen (1980) using a TKO 100 Fluorometer (Hoefer Scientific Instruments, San Francisco, CA). Calf thymus DNA (Sigma Chemical, St. Louis, MO) was used to generate standard curves, and Hoescht dye no. 33258 (Polysciences, Warrington, PA) was used as the fluorimetric reagent. Standard DNA regression equations were used to calculate the sample DNA content. Experimental procedures were conducted according to those approved by the University of Illinois Laboratory Animal Care Advisory Committee.
Statistical Analysis. Treatments were similar among the three trials; however, the trials were not pooled and were analyzed individually due to differences in location, breed, and diet. The independent variables, dietary energy, bST treatment and their interaction were evaluated using the residual mean square as the error term with the GLM procedure of SAS (1990) . Animal was used as the experimental unit. There were no significant dietary treatment × bST treatment interactions for any of the variables analyzed in any of the three trials ( P > .05), and therefore only the main effects are presented. Due to removal of animals during the study, data were analyzed by least squares procedures for unequal subclass numbers. Model sums of squares were partitioned into treatment effects that were separated using a significant F-test. Heifer performance data were analyzed using heifer age as a covariate. Milk production and calf performance data were analyzed using age of dam, calf age, and calf sex as covariates. The effects of dietary energy and bST on concentrations of serum IGF-I and bST were determined using GLM procedures (SAS, 1990) for a split plot in time design with repeated measurements (Gill and Hafs, 1971) . The repeated-measures model included dietary energy and bST treatments, day, and their interactions as independent variables. Animal within treatment was used as the error term. Previous results suggested that lower-energy diets (Sejrsen et al., 1982; 1983) or somatotropin treatment (Sejrsen et al., 1986; Sandles et al., 1987 ) have a positive effect on heifer mammary parenchyma development. Therefore, tests of the effects of dietary or somatotropin treatment on mammary DNA, DFFT, and protein, milk production, and calf growth were one-sided, the alternative hypothesis being that moderate energy or somatotropin would increase these measures. Other tests were two-sided because there was no a priori reason to favor a particular hypothesis. The linear relationship between heifer ADG, fat thickness, mean milk production, and mammary gland measurements were evaluated using CORR procedures of SAS (1990) . The level of probability at which effects were considered significant was P < .05.
Results
Growth Traits. In Trial 1, heifers receiving HDE had a reduction in DMI ( P < .01) and a 19% improvement in feed efficiency compared to heifers fed MDE (Table 2) . Treatment with bST did not significantly influence DMI; however, feed efficiency was improved by 13% ( P < .01). Heifers fed MDE gained weight more rapidly during the 112-d treatment period than predicted by NRC (1984) ( Table 3) . Although there was no difference in ADG or skeletal growth ( P > .10), fat thickness at the end of the treatment period was greater for heifers fed HDE ( P < .05). Heifers receiving bST had an increase in ADG of 19% and greater hip height growth compared to those given VEH ( P < .05). There were no apparent longterm effects of dietary or bST treatment on body weight, hip height, body condition, or pelvic area following the treatment period.
In Trial 2, heifers that consumed HDE were 26 kg heavier ( P < .01) at weaning, having gained 30% more ( P < .01) during the treatment period than heifers receiving MDE (Table 4) . Heifers receiving HDE also had greater hip height growth ( P < .01) and fat thickness ( P < .01) by the conclusion of the treatment period. Treatment period daily gain was increased by 10% for bST-treated heifers ( P < .01). No other growth traits were affected by bST treatment. In Trial 3, heifers supplied HDE gained at nearly twice the rate of those given MDE ( Table 5 ). Heifers that received HDE were 52 kg heavier at weaning ( P < .01) than heifers fed MDE. Fat thickness and hip height were both increased by HDE ( P < .01). Weight, hip height, and condition score at breeding were greater ( P < .05) for heifers supplied HDE. In contrast to Trials 1 and 2, bST treatment had no significant effect on growth.
Somatotropin and IGF-I. As measured in Trial 1
from d 99 to 112 of the treatment period, there were both dietary energy and bST treatment effects on serum somatotropin concentration ( P < .01) (Figures  1 and 2 ). Heifers receiving HDE had lower ( P < .01) circulating concentrations of somatotropin compared to MDE-fed heifers (3.0 vs. 5.4 ng/mL, respectively). Somatotropin treatment increased bST concentration in the serum from 3.1 ng/mL in VEH-treated heifers to 5.4 ng/mL in bST-treated heifers ( P < .01). There was no significant effect of dietary treatment on serum IGF-I concentration during the 112-d treatment period (Figure 3 ). Treatment with bST increased the mean serum concentration of IGF-I to 170 ng/mL, compared with 148 ng/mL for VEH treatment ( P < .05) ( Figure  4) . Concentration of IGF-I in the serum did not differ due to treatment from d 126 to d 168 of the trial (data not presented). Reproductive Traits. Reproductive performance of heifers is given in Table 6 . Heifers in Trial 1 provided HDE tended ( P = .14) to reach puberty at a younger age. Administration of bST tended ( P = .08) to increase weight at puberty. No treatment effects were observed for the percentage of heifers that were pubertal before the breeding season, pregnancy rate, or first-service calving rates.
The percentage of heifers that were pubertal at the start of the breeding season tended ( P = .15) to be increased when exposed to creep feed (HDE) in Trial 2. No other dietary or bST treatment differences were detected for Trial 2.
In Trial 3, there was a tendency for more heifers that received HDE to be pubertal before the breeding season ( P = .10) and to become pregnant ( P = .09). There was also a tendency ( P = .10) for bST-treated heifers to have a decreased pregnancy rate.
In all three trials, there were no significant effects of treatments on calving ease or percentage of unassisted births (data not shown).
Milk Production and Calf Growth. Milk production
and composition were unaffected by dietary energy or bST treatment in Trial 1 (Table 7) . Calf weights at birth and 49 d of age were significantly increased for dams fed HDE. In Trial 2, mean milk production was decreased 20% for HDE-fed dams ( P < .05) and resulted in calves that weighed 16 kg less ( P < .05) and tended ( P = .06) to have less hip height at weaning compared to MDE fed dams (Table 8) . There was no effect on milk composition due to dietary treatment. Treatment with bST did not affect milk production, milk composition, or calf growth.
In Trial 3, although not statistically different, milk production and calf weights following birth were numerically lower for HDE-fed dams at all times measured (Table 9) . Treatment with bST signifi- cantly increased milk production at two of the five times measured and tended ( P = .08) to result in greater mean milk production. Milk composition was similar ( P < .05) for VEH and bST-treated animals.
Weights were increased at 49, 77, 105, 133, and 161 d of age for calves with bST-treated dams ( P < .05).
Calf weaning weights at 161 d of age were increased by 8 kg for bST-treated dams ( P < .05).
Mammary Gland Composition. Mammary gland composition was unaffected ( P > .10) by dietary energy or bST treatment in Trial 1 (Table 10) . In Trial 2, HDE-treated dams had 20% less mammary gland wet weight ( P < .05), 24% less DFFT ( P < .05), 43% less ash ( P < .01), and 32% less DNA ( P < .05) than MDE-treated dams. Dietary energy treatment did not significantly affect dry weight, protein, fat, or concentration of DNA in DFFT of the mammary glands. Somatotropin treatment did not affect mammary gland composition ( P > .10).
Correlation coefficients between milk production estimates and mammary gland characteristics for Trials 1 and 2 are presented in Table 11 . Average daily gain during the 112-d treatment period was negatively correlated to mammary gland wet weight ( P < .05), DFFT ( P < .01), and DNA ( P < .01) and tended to be negatively correlated to mean milk production ( P = .06) and protein content of the mammary gland ( P = .09). Fat thickness at the end of the treatment period was also negatively correlated to mean milk production ( P < .05) and DNA content of the mammary gland ( P < .001). Mean milk production was related positively to wet weight DFFT, protein, ash, and DNA content ( P < .001). Dry fat-free tissue, protein, ash, and DNA contents of the glands were all positively related ( r ≥ .66; P < .001). The concentration of DNA in the DFFT was not correlated to mean milk production or ADG during the treatment period but was related negatively to fat thickness at the end of the treatment period ( P < .001).
Discussion
Growth Traits. Feed efficiency was improved for bST-treated heifers in Trial 1. The enhancement of feed conversion by exogenous bST administration has been demonstrated in heifers (McShane et al., 1989a; Vestergaard et al., 1995) and steers (Dalke et al., 1992; Moseley et al., 1992) and may be caused by more efficient nitrogen retention in bST-treated animals (Eisemann et al., 1986; Crooker et al., 1990) .
Exogenous somatotropin increased gain in Trials 1 and 2 when ADG was > 1 kg/d but not in Trial 3 when ADG was < 1 kg/d. These results are similar to those of Hufstedler et al. (1992) , who found that Angus × Holstein heifers treated with bST gained 20% faster when fed a high-concentrate diet but gained no differently from controls when subjected to periods of restricted growth. Administration of bST to growing heifers gaining < 1 kg/d has been shown to increase ADG (Sandles et al., 1987; McShane et al., 1989a) , whereas Hall et al. (1994) failed to show a weight Grings et al. (1990), and Hall et al. (1994) . However, lack of hip height differences in Trials 2 and 3 is similar to results reported by Hawkins et al. (1992) .
Previous reports have shown increased pelvic area for heifers treated with bST (McShane et al., 1989a; Grings et al., 1990; Hawkins et al., 1992) . In those studies, pelvic area was measured during bST treatment and no later than approximately 19 mo of age. Increased pelvic opening caused by bST treatment would be of little consequence unless it was maintained through the time of calving when pelvic area may influence dystocia (Rice and Wiltbank, 1972) . We observed no significant differences in pelvic area at breeding, pelvic area at calving, calving ease scores or percentage of unassisted births due to treatment.
Somatotropin and IGF-I. Elevated concentration of
bST in serum has been demonstrated in prepubertal dairy and beef heifers fed restricted-energy diets compared with those fed a high plane of nutrition (Sejrsen et al., 1983; Houseknecht et al., 1988) . Likewise, the heifers in Trial 1 fed HDE had decreased levels of bST in serum compared to those fed MDE. It is well established that energy-deficient diets result in reduced circulating IGF-I concentration even when accompanied by increased bST concentration (Clemmons and Underwood, 1991; McGuire et al., 1992) . This uncoupling of the bST/IGF-I axis may serve the metabolic function of energy mobilization from adipose tissue (Bauman and Currie, 1980) . Our energy restriction, in the MDE treatment, was not severe and therefore IGF-I concentrations were unaffected by dietary energy treatment.
As expected from previous studies, administration of exogenous bST increased concentrations of bST and IGF-I in serum (McShane et al., 1989b; Crooker et al., 1990) . Our data revealed a 15% increase in circulating IGF-I concentration in bST-treated animals even though samples were obtained 14 d following bST administration.
Reproductive Traits. Previous research has well established that age at puberty decreases with increased planes of nutrition (Wiltbank et al., 1969; Short and Bellows, 1971) . We too found trends for reduced age at puberty and greater numbers of heifers pubertal before the breeding season when fed HDE. In our current study, when more than 60% of heifers were pubertal before breeding, there was no dietary energy effect on pregnancy rates following a 60-d breeding season. This agrees with results by Buskirk et al. (1995) . When only 40% of heifers were pubertal before breeding, in Trial 3, previous HDE intake increased pregnancy rates, similar to an earlier report by Short and Bellows (1971) .
The critical event leading to the onset of puberty in cattle seems to be the increase in frequency of LH pulses (Schillo, 1992) . Chronic treatment with bST does not alter patterns of LH secretion in prepubertal beef heifers (Hall et al., 1994 ) and therefore would not be expected to alter attainment of puberty. Our results confirm previous findings that suggest no difference in the age at which bST-treated heifers reach puberty compared to controls (McShane et al., 1989a; Murphy et al., 1991; Hall et al., 1994) . In contrast, Angus × Holstein heifers, given twice the dosage of bST supplied in our trials, exhibited delayed puberty (Hawkins et al., 1992) . We observed a tendency for increased weight at puberty for bSTtreated heifers; however, Murphy et al. (1991) and Hall et al. (1994) observed no differences in weight at first ovulation. Our noted trend for decreased pregnancy rates in bST-treated heifers is not consistent with other reports (Grings et al., 1990; Murphy et al., 1991) .
Milk Production and Calf Growth. Diets high in energy fed to prepubertal dairy heifers have resulted in reduced subsequent milk production (Swanson, 1960; Gardner et al., 1977; Sejrsen, 1978; Little and Kay, 1979; Little and Harrison, 1981; Park et al., 1987) . The MDE-treated heifers exceeded NRC (1984) predictions of DMI and ADG in Trial 1. As a result, there was no significant difference between HDE and MDE treatments in ADG during the 112-d treatment period, and there was no observed milk production difference in Trial 1 due to dietary treatment.
In Trial 2, creep feeding did increase rates of gain, and these heifers had decreased subsequent milk production and calf performance. It has been shown previously that creep feeding high-energy feedstuffs to prepubertal beef heifers may decrease subsequent milk production (Hixon et al., 1982; Cremin, 1989; Buskirk et al., 1996) and reduce calf weight gains (Martin et al., 1981) . Although not statistically significant, the comparison of milk production between dietary energy treatments in Trial 3 was numerically similar to that in Trial 2. Lack of a significant negative response to HDE in Trial 3 may have been a result of overall lower ADG, and(or) grazing of endophyte-infected fescue. Creep feeding of heifers may not limit milk production if ADG is restricted by limiting either the quantity of creep feed (Cremin, 1989) or time exposed to creed feed (Buskirk et al., 1996) . Another possible explanation is that milk production in Trial 3 was lower than some previous reports for Angus and Angus-Hereford primiparous heifers (Hixon et al., 1982; Sacco et al., 1987) . Beef heifers grazing endophyte-infected tall fescue often have low milk production (Buskirk et al., 1995 (Buskirk et al., , 1996 that can be suppressed by as much as 50% (Schmidt et al., 1986 ). This may not have allowed heifers in Trial 3 to fully express treatment differences in lactation.
Previous reports have shown an increase in mammary parenchymal tissue in the prepubertal dairy heifer administered bST (Sejrsen et al., 1985; Sandles et al., 1987; Purup et al. 1993) ; however, there is a lack of evidence indicating a consistent increase in subsequent milk production (Vicini et al., 1995) . Milk production and resulting calf growth were increased in bST-treated dams in Trial 3, but not in Trials 1 or 2. The reason for this is not entirely clear. The dosage of bST was the same in all three trials; however, the quantity of bST/kg of body weight was highest in Trial 3. Purup et al. (1993) reported an increase in prepubertal mammary parenchymal protein with similar bST dosage per body weight as in Trials 1 and 2. We hypothesized that high ADG, as in Trials 1 and 2, would decrease serum somatotropin concentrations and be even more limiting to mammary parenchyma development, resulting in a greater response to bST treatment. Our results do not support this hypothesis, especially in light of demonstrating no interactions between dietary energy and bST treatment. Hall et al. (1992) reported that bST treatment of beef heifers did overcome the negative effects of HDE on calf weaning weights over three parities. Even though there was not a positive response in lactation to bST treatment compared to VEH in Trials 1 and 2, it is interesting that bST treatment significantly increased ADG during the treatment period with no detrimental effect on milk production. In understanding the nutritional regulation of mammary development and subsequent milk production, we may also need to consider regulation of IGF-I by its binding proteins, mammary tissue sensitivity to hormones, and possible roles of other hormones and growth factors (Peri et al., 1993; Purup et al., 1993; Sejrsen et al., 1995) .
Mammary Gland Composition.
From about 3 to 9 mo of age is an especially critical period in mammogenesis. Total cell numbers in the mammary gland, as quantified by DNA, have been shown to increase 1.6 times faster than body weight between birth and 2 mo of age. The comparable value increased to 3.5 between 5 and 9 mo and then decreased to 1.5 from 9 to 12 mo of age (Sinha and Tucker, 1969 ). An increased plane of nutrition during this critical period has been shown to reduce mammary parenchymal tissue of dairy heifers (Sejrsen et al., 1982 (Sejrsen et al., , 1983 . Heifers exposed to creep feed in Trial 2 had decreased mammary gland DFFT and DNA contents compared to heifers not given creep feed. These estimators of secretory tissue and milk production estimates for HDE-fed heifers were decreased by a similar magnitude.
Lactation potential is determined by epithelial cell number and by secretory activity per cell (Forsyth, 1986; Knight and Wilde, 1987) , with cell number ultimately being the limiting factor (McGrath, 1987) . Correlation coefficients between total mammary cell numbers and milk yield have been reported to range between .50 and .85 (Tucker, 1966) . Our present findings also fall within this range ( r = .73).
Insulin-like growth factor I is increased by exogenous administration of bST (McShane et al., 1989b; Crooker et al., 1990) and can stimulate multiple cellular responses related to tissue growth, including synthesis of DNA and cellular protein (Clemmons and Underwood, 1991) . This suggests that mammary DNA concentration in DFFT may be expected to increase during treatment with bST. The concentration of mammary gland DNA in DFFT has been increased in prepubertal heifers receiving restricted energy (Sejrsen et al., 1982 (Sejrsen et al., , 1983 or exogenous bST (Purup et al., 1993) when measured before lactation. This is supportive of the theory that nutritional regulation of mammary cell differentiation and growth involves the somatotropin/IGF-I axis (Sejrsen et al., 1983 (Sejrsen et al., , 1986 . Our measurements of DNA/DFFT in lactating glands, however, indicated no treatment differences in this ratio. In contrast to studies that have shown an increase in mammary parenchyma and a decrease in extraparenchyma tissue in prepubertal bST-treated heifers shortly following treatment (Sejrsen et al., 1986; Sandles et al., 1987; Purup et al., 1993) , we observed no alteration in mammary composition at the end of the first lactation. The results of others, along with those of the present study, suggest that bST treatment of the prepubertal heifer may increase the rate of mammary cell growth during therapy but not consistently affect subsequent epithelial cell quantity in the lactating gland. We did observe higher milk production in bST-treated dams in Trial 3 but did not examine mammary composition in that trial.
Implications
Beef heifer feeding practices that include high energy intake before puberty may impair future milk production and calf growth by reducing the amount of parenchyma tissue in the mammary gland. This reduction in lactation ability was not overcome by prepubertal administration of bST. There are likely other mediators involved with the reduction in mammary development seen in heifers receiving a high plane of nutrition.
